(Q48361734)

11 February 2018

title

Strategies for in vivo measurement of receptor binding using positron emission tomography. (English)

1 reference

11 February 2018

3

Raichle ME

1 reference

11 February 2018

5

Mintun MA

1 reference

11 February 2018

Joel S Perlmutter

1

object named as

Perlmutter JS

1 reference

11 February 2018

author name string

Larson KB

2

1 reference

11 February 2018

Markham J

4

1 reference

11 February 2018

Kilbourn MR

6

1 reference

11 February 2018

Welch MJ

7

1 reference

11 February 2018

publication date

1 April 1986

1 reference

11 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

11 February 2018

volume

6

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

154-169

1 reference

11 February 2018

describes a project that uses

positron emission tomography

1 reference

Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Dopaminergic receptor sites in human brain: positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Measurement of regional cerebral blood volume by emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Dopamine receptor binding in vivo: The feasibility of autoradiographic studies

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

External detection of early microvascular dysfunction after no-flow ischemia followed by reperfusion in isolated rabbit hearts

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Ultrafiltration in serum protein binding determinations.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1986.29

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1986.29

1 reference

11 February 2018

1 reference

11 February 2018